Exponent/$EXPO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Exponent
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Ticker
$EXPO
Sector
Primary listing
Industry
Professional Services
Headquarters
Employees
966
ISIN
US30214U1025
Website
Exponent Metrics
BasicAdvanced
$3.8B
36.35
$2.04
0.96
$1.16
1.62%
Price and volume
Market cap
$3.8B
Beta
0.96
52-week high
$114.30
52-week low
$72.43
Average daily volume
318K
Dividend rate
$1.16
Financial strength
Current ratio
3.322
Quick ratio
3.162
Long term debt to equity
16.875
Total debt to equity
18.151
Dividend payout ratio (TTM)
55.92%
Profitability
EBITDA (TTM)
143.133
Gross margin (TTM)
39.16%
Net profit margin (TTM)
20.34%
Operating margin (TTM)
25.69%
Effective tax rate (TTM)
27.09%
Revenue per employee (TTM)
$540,000
Management effectiveness
Return on assets (TTM)
11.96%
Return on equity (TTM)
25.87%
Valuation
Price to earnings (TTM)
36.349
Price to revenue (TTM)
7.32
Price to book
8.54
Price to tangible book (TTM)
8.79
Price to free cash flow (TTM)
28.299
Free cash flow yield (TTM)
3.53%
Free cash flow per share (TTM)
262.06%
Dividend yield (TTM)
1.56%
Forward dividend yield
1.62%
Growth
Revenue change (TTM)
2.58%
Earnings per share change (TTM)
3.59%
3-year revenue growth (CAGR)
5.39%
10-year revenue growth (CAGR)
5.90%
3-year earnings per share growth (CAGR)
2.77%
10-year earnings per share growth (CAGR)
10.38%
3-year dividend per share growth (CAGR)
10.72%
10-year dividend per share growth (CAGR)
15.82%
What the Analysts think about Exponent
Analyst ratings (Buy, Hold, Sell) for Exponent stock.
Bulls say / Bears say
Exponent Inc. reported quarterly adjusted earnings of 46 cents per share for the quarter ended December 31, 2024, surpassing analyst expectations of 40 cents, indicating strong financial performance. (reuters.com)
The company raised its revenue and margin expectations for the year, reflecting confidence in its strategic initiatives and market position. (investing.com)
Exponent is focusing on strategic recruitment and development for growth and profitability, with AI-related projects, particularly in advanced driver assistance and medical devices, gaining increased relevance. (investing.com)
The company's CFO, Richard L. Schlenker Jr., sold approximately $4.3 million worth of company shares, which could be perceived as a lack of confidence in the company's future performance. (investing.com)
Exponent's environmental and health segment experienced a 3% revenue decrease in the fourth quarter, impacted by client budget constraints leading to delays in litigation work. (exponent.com)
The company anticipates revenues before reimbursements to be flat to down modestly in 2024, indicating potential challenges in maintaining growth momentum. (exponent.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.
Exponent Financial Performance
Revenues and expenses
Exponent Earnings Performance
Company profitability
Exponent News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Exponent stock?
Exponent (EXPO) has a market cap of $3.8B as of June 30, 2025.
What is the P/E ratio for Exponent stock?
The price to earnings (P/E) ratio for Exponent (EXPO) stock is 36.35 as of June 30, 2025.
Does Exponent stock pay dividends?
Yes, the Exponent (EXPO) stock pays dividends to shareholders. As of June 30, 2025, the dividend rate is $1.16 and the yield is 1.62%. Exponent has a payout ratio of 55.92% on a trailing twelve-month basis.
When is the next Exponent dividend payment date?
The next Exponent (EXPO) dividend payment date is unconfirmed.
What is the beta indicator for Exponent?
Exponent (EXPO) has a beta rating of 0.96. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.